EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and 177 Lu-PSMA Therapy Between Centers in Brazil and Europe

Juliano J Cerci, Stefano Fanti, Ken Herrmann, Denise Ferreira Rodrigues, Pedro Henrique Furst Leite, Margaret Masukawa, Marcelo Moreira da Silva, Wolfgang P Fendler, Adriano Goncalves E Silva, Elise Nara Sanfelice, Walter Ayelet, Fabio Ghetti und 3 weitere

Journal of Nuclear Medicine · 2026-11 · 67 (11) · 1778-1780

DOI: 10.2967/jnumed.126.273029 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 20.08.2026. Verfasst von Juliano J Cerci und 14 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Teranóstico Brasil, Curitiba, Brazil; cercijuliano@hotmail.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lutetium, Radioisotopes, Prostatic Neoplasms. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Real-world disparities in access to PSMA-targeted theranostics are poorly characterized. We compared waiting times for PSMA PET/CT and 177Lu-PSMA therapy between centers in Brazil and Europe.

Methods

This retrospective multicenter study included 91 patients (50 from Brazil, 41 from Europe) treated with 177Lu-PSMA. Outcomes were days from request to PSMA PET/CT completion (diagnostic access) and days from request to first therapy dose (therapeutic access). Groups were compared using the Mann-Whitney U test.

Results

Diagnostic access was similar between Brazil (median, 17.5 d; interquartile range [IQR], 9-34 d) and Europe (median, 19 d; IQR, 14-23 d; P = 0.39). Therapeutic access was significantly delayed in Brazil (median, 59 d; IQR, 54.5-91) compared with Europe (median, 21 d; IQR, 17-31 d; P < 0.01), representing a 2.8-fold longer wait.

Conclusion

Despite comparable access to PSMA PET/CT, initiation of 177Lu-PSMA therapy is nearly 3 times slower in Brazil than in Europe. Closing the therapeutic access gap requires targeted investments in radiopharmaceutical supply chains and regulatory efficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLutetiumRadioisotopesProstatic NeoplasmsHealthcare DisparitiesTheranostic NanomedicineAntigens, SurfaceGlutamate Carboxypeptidase IIHealth Services AccessibilityDipeptidesHumansBrazilEuropeRetrospective StudiesMaleAgedMiddle AgedRadiopharmaceuticalsProstate-Specific Antigen

Stichwörter der Autor:innen

177Lu-PSMAaccess gapprostate cancerradionuclide therapyradiopharmaceutical therapytheranostics

Substanzen

LutetiumRadioisotopesLutetium-177Antigens, SurfaceGlutamate Carboxypeptidase IIlutetium (177Lu) vipivotide tetraxetanDipeptidesFOLH1 protein, humanRadiopharmaceuticalsProstate-Specific Antigen

Autor:innen und Institutionen

  • Instituto Teranóstico Brasil, Curitiba, Brazil; cercijuliano@hotmail.com.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Nuclear Medicine, West German Cancer Center, DKTK and NCT Site, University Hospital Essen, Essen, Germany.
  • Instituto Teranóstico Brasil, Curitiba, Brazil.
  • Department of Nuclear Medicine, IMEB-Institute of Nuclear Medicine of Brasília, Brasília, Brazil.
  • Instituto do Cancer e Transplante, Curitiba, Brazil.

Zitieren

APA

Cerci, J. J., Fanti, S., Herrmann, K., Rodrigues, D. F., Leite, P. H. F., Masukawa, M., da Silva, M. M., Fendler, W. P., Goncalves E Silva, A., Sanfelice, E. N., Ayelet, W., Ghetti, F., Bascioni, A., Estrado Lobato, E. E., & Paez, D. (2026). The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and 177 Lu-PSMA Therapy Between Centers in Brazil and Europe. Journal of Nuclear Medicine, 67(11), 1778-1780. https://doi.org/10.2967/jnumed.126.273029

Vancouver

Cerci JJ, Fanti S, Herrmann K, Rodrigues DF, Leite PHF, Masukawa M, et al. The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and 177 Lu-PSMA Therapy Between Centers in Brazil and Europe. Journal of Nuclear Medicine. 2026;67(11):1778-1780. doi:10.2967/jnumed.126.273029

BibTeX
@article{Cerci2026,
  author = {Cerci, Juliano J and Fanti, Stefano and Herrmann, Ken and Rodrigues, Denise Ferreira and Leite, Pedro Henrique Furst and Masukawa, Margaret and da Silva, Marcelo Moreira and Fendler, Wolfgang P and Goncalves E Silva, Adriano and Sanfelice, Elise Nara and Ayelet, Walter and Ghetti, Fabio and Bascioni, Andrea and Estrado Lobato, Enrique E and Paez, Diana},
  title = {The Global Theranostics Access Gap: Real-World Disparities in PSMA PET/CT and 177 Lu-PSMA Therapy Between Centers in Brazil and Europe},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  volume = {67},
  number = {11},
  pages = {1778--1780},
  doi = {10.2967/jnumed.126.273029}
}
Kostenlos starten →